Kate R. Muller, Robert Padbury, Gary P. Jeffrey, Nicola K. Poplawski, Philip Thompson, Anne Tonkin, Hugh A. J. Harley – 15 January 2010 – Transthyretin amyloid polyneuropathy, caused by mutations in the transthyretin gene, is a progressive condition for which liver transplantation is an established treatment. Favorable outcomes have been described in patients with the most common transthyretin mutation, Val30Met, but outcomes have been variable in patients with other mutations.

Vinod K. Audimoolam, Mathew R. Foxton, Kosh Agarwal, John G. O'Grady, Michael A. Heneghan – 15 January 2010

Walid Mohamed El Moghazy, Yasuhiro Ogura, Kouji Harada, Akio Koizumi, Shinji Uemoto – 15 January 2010 – Several studies have shown improved growth after liver transplantation, but long‐term follow‐up data have been lacking. This study was aimed at evaluating the ability of children to catch up in height after living donor liver transplantation (LDLT) and at clarifying factors affecting growth. Growth was assessed by serial height measurements performed during follow‐up.

James Neuberger – 15 January 2010

Christoph Schramm, Michael Bubenheim, René Adam, Vincent Karam, John Buckels, John G. O'Grady, Neville Jamieson, Stephen Pollard, Peter Neuhaus, Michael M. Manns, Robert Porte, Denis Castaing, Andreas Paul, Oscar Traynor, James Garden, Styrbjörn Friman, Bo‐Goran Ericzon, Lutz Fischer, Stefan Vitko, Marek Krawczyk, Herold J. Metselaar, Aksel Foss, Murat Kilic, Keith Rolles, Patrizia Burra, Xavier Rogiers, Ansgar W.

Glauber Gouvêa, Rodrigo Diaz, Lúcio Auler, Renato Toledo, André Soluri, Alfredo G. Haack, Mariana M. de Oliveira, Bruno Vilanova, Virgínia R. Machado, José Manoel Martinho – 15 January 2010 – Transient postoperative coagulation abnormalities frequently occur in living liver donors, particularly after right liver resection. Usually, this coagulopathy is diagnosed by alterations in conventional coagulation tests (CCTs) such as the international normalized ratio (INR) of the prothrombin time.

Shin Hwang, Sung‐Gyu Lee, Deok‐Bog Moon, Gi‐Won Song, Chul‐Soo Ahn, Ki‐Hun Kim, Tae‐Yong Ha, Dong‐Hwan Jung, Kwan‐Woo Kim, Nam‐Kyu Choi, Gil‐Chun Park, Young‐Dong Yu, Young‐Il Choi, Pyoung‐Jae Park, Hea‐Seon Ha – 15 January 2010 – ABO incompatibility is the most common cause of donor rejection during the initial screening of adult patients with end‐stage liver disease for living donor liver transplantation (LDLT). A paired donor exchange program was initiated to cope with this problem without ABO‐incompatible LDLT.

Patrick G. Northup, Curtis K. Argo, Mihir R. Bakhru, Timothy M. Schmitt, Carl L. Berg, Mitchell H. Rosner – 15 January 2010 – The Model for End‐Stage Liver Disease system has given priority on the liver transplant waiting list to candidates with renal failure. This study determined the predictors of spontaneous recovery of renal function after transplantation in 1041 liver transplant recipients on renal replacement therapy (RRT) at the time of transplant (from February 2002 to January 2007).

Rodrigo Zapata, Mario Uribe, Waldo Martínez, Alejandro Andrade, José Luis Leal, Fernando Gomez – 15 January 2010 – In 2009, the World Health Organization recognized the novel H1N1 influenza A virus as a pandemic infection. Since April 2009, thousands of cases of novel H1N1 influenza A infection have been reported worldwide, and they have resulted in thousands of deaths. South American countries were affected by this infection during their winter season, and Chile presented one of the highest incidence rates.

Gi‐Won Song, Sung‐Gyu Lee, Shin Hwang, Ki‐Hum Kim, Chul‐Soo Ahn, Deok‐Bog Moon, Tae‐Yong Ha, Seog‐Woon Kwon, Gi‐Young Ko, Kyoung‐Won Kim – 15 January 2010 – ABO blood group compatibility has been regarded as an essential prerequisite for successful adult living donor liver transplantation (LDLT). Novel strategies for overcoming the ABO blood group barrier, however, have markedly improved the results of ABO‐incompatible (ABOi) LDLT.